LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Home・Aktien・Boston Scientific Corp.

Boston Scientific Corp.

Geschlossen

BrancheGesundheitswesen

52.65 -1.74

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

52.51

Max

54.33

Schlüsselkennzahlen
By Trading Economics
Einkommen	669M 1.3B
Verkäufe	-83M 5.2B
KGV Branchendurchschnitt	22.331 51.415
EPS	0.8
Gewinnspanne	25.774
Angestellte	59,000
EBITDA	116M 1.1B

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+66.42% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	29. Juli 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-11B 79B
Vorheriger Eröffnungskurs	54.39
Vorheriger Schlusskurs	52.65

Nachrichtenstimmung

By Acuity

24%

76%

42 / 345 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

102.95 / 104.93 Unterstützung & Widerstand

Boston Scientific Corp. Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

Boston Scientific Corp. Prognose

Kursziel

By TipRanks

66.42% Vorteil

12-Monats-Prognose

Durchschnitt 89.12 USD 66.42%

Hoch 118 USD

Tief 71 USD

Basierend auf 27 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Boston Scientific Corp. – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

27 ratings

Buy

Halten

Sell

Basierend auf 27 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Boston Scientific Corp. – Dist abgegeben haben.

Technischer Score

By Trading Central

102.95 / 104.93Unterstützung & Widerstand

All events are bullish.

Recent bearish events outweigh bullish events.

There are no events.

Stimmung

By Acuity

42 / 345 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Boston Scientific Corp.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.